Indo US Bio-Tech Board of Directors

Get the latest insights into the leadership at Indo US Bio-Tech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dimpy JoshiCompany Secretary & Compliance Officer
Jagdish AjudiaManaging Director
Maltiben AjudiaWhole Time Director
Priyanka AjudiaExecutive Director
Neha PatelNon Executive Independent Director
Shilpa ThumarNon Executive Independent Director
Ritaben Nileshbhai KikaniNon Executive Independent Director

Indo US Bio-Tech Share price

INDOUS

102.51

2.67 (-2.54%)
NSE
BSE
Last updated on 24 Apr, 2026 | 15:31 IST
Today's High

108.01

Today's Low

102.10

52 Week Low

96.05

52 Week High

206.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Indo US Bio-Tech FAQs

The board at Indo US Bio-Tech consists of experienced professionals, including Dimpy Joshi, Jagdish Ajudia, and others, overseeing the company’s strategic and corporate governance.

Directors at Indo US Bio-Tech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dimpy Joshi is the current chairman at Indo US Bio-Tech.

Executive directors at Indo US Bio-Tech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Indo US Bio-Tech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Indo US Bio-Tech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost